Annexon

Annexon Current Assets

The Current Assets of Annexon (ANNX) as of Oct 11, 2026 is 242.19 M USD. In the previous year, Current Assets was 316.46 M USD — a change of -23.47% (lower).

Current Assets

242.19 MUSD

YoY

-23.47%

Last updated:

Current Assets of Annexon is 2025 242.19 M USD. Current Assets of Annexon was 2024 316.46 M USD. It decreases by -23.47% lower compared to the previous year.

The Annexon Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
45.48 M USD
Jan 1, 2019
45.33 M USD
Jan 1, 2020
354.01 M USD
Jan 1, 2021
247.69 M USD
Jan 1, 2022
248.10 M USD
Jan 1, 2023
263.86 M USD
Jan 1, 2024
316.46 M USD
Jan 1, 2025
242.19 M USD
The Annexon Current Assets history
YEARCurrent AssetsYoY
242.19 MUSD-23.47%
316.46 MUSD+19.94%
263.86 MUSD+6.35%
248.10 MUSD+0.16%
247.69 MUSD-30.03%
354.01 MUSD+681.01%
45.33 MUSD-0.34%
45.48 MUSD+955.00%
4.31 MUSD—
Access this data via the Eulerpool API
Get Free API Key

Annexon Stock analysis

What does Annexon do? Annexon Inc is a biopharmaceutical company based in South San Francisco, California. It was founded in 2011 by Doug Love, Ted Love, and Arnon Rosenthal, who had previously worked at major pharmaceutical companies such as Genentech and Novartis. The company's main goal is to develop new treatment options for neurodegenerative diseases, focusing on the development of drugs that target the autophagy process in cells to reduce damage to nerve cells and alleviate symptoms. Annexon Inc has two divisions, Annexon Biosciences and Annexon Clinical, with partnerships with renowned pharmaceutical companies to advance drug development. Its main product is ANX005, a therapeutic antibody protein that targets the role of the complement system in neurodegenerative diseases. Annexon Inc has received multiple awards for its work and innovations and has a dedicated team of scientists and executives committed to improving the lives of people with neurodegenerative diseases. Annexon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Annexon stock

Current Assets of Annexon is 242.19 M USD in 2025.

Current Assets of Annexon changed from 316.46 M USD to 242.19 M USD, representing a -23.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Annexon since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Annexon historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Annexon

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Annexon